| Term 
 
        | main difference between 1st and 2nd generation AEDs with respect to tolerability and drug interactions |  | Definition 
 
        | tolerability: 1st generation AEDs have more ADRs
 
 drug interaction potential:
 1st generation AEDs have higher potential for drug interactions
 |  | 
        |  | 
        
        | Term 
 
        | those seizures where initial onset arises from a localized area of the brain 
 most common type of seizure experienced by adults
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | characteristics of simple partial seizures |  | Definition 
 
        | no loss of consciousness 
 arise from disturbances in specific areas of cortex and abnormal discharges remain unilateral
 
 symptoms are appropriate to function of discharging area of brain and may be motor, somatosensory, special sensory, or a combination
 
 duration:  30 seconds or less
 
 no postictal phse, although some patients may have temporary numbness or weakness of affected extremity
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of complex partial seizures |  | Definition 
 
        | IMPAIRED CONSCIOUSNESS: refers to patients' ability to normally interact and respond to their environment
 patients may appear to be conscious, but are unaware of their environment
 fail to respond or respond inappropriately to questions
 afterward, are unable to remember the episode
 
 complex partial seizures involve portions of brain concerned with maintenance on consciousness and memory
 
 ASSOCIATED WITH INITIAL AURA (i.e. simiple partial seizure which may then progress to a complex partial seizure)
 
 most common forms of aura:  fear, rising epigastric sensation, unilateral "funny feeling" or "numbness", visual disturbances
 
 simple to complex automatisms (repetitive motor activity that is purposeless, undirected, and inappropriate) are frequently observed during complex partial seizures
 
 repetitive chewing or swallowing, lip smacking, fumbling movements of fingers or hands, picking at clothing, mumbling, moving about aimlessly, purposeless behavior, and clumsy perseverance of a preceding motor act
 
 duration: 1-3 minutes
 
 postictal phase:  confusion, lethargy, altered behavior, amnesic for event
 
 most common seizure type seen in adult epilepsy
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of partial seizures secondarily generalized |  | Definition 
 
        | partial seizure may progress through several stages reflecting spread of discharge to different brain areas 
 ex) seizure may begin as simple partial (aura), progress to complex partial, and subsequently become secondarily generalized (tonic-clonic)
 |  | 
        |  | 
        
        | Term 
 
        | seizures where first clinical changes indicate initial involvement of both hemispheres 
 the initial clinical event is loss of consciousness
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | characteristics of generalized tonic-clonic seizures (grand mal) |  | Definition 
 
        | loss of consciousness is quickly followed by a sudden fall to ground 
 tonic phase:
 muscles become rigid and the simultaneous contractions of diaphragm and chest muscles may produce the characteristic "epileptic cry"
 patient's eyes roll up or turn to the side and tongue may be bitten
 
 clonic phase:
 the rigidity is replaced shortly by series of synchronous clonic movements of head, face, legs and arms
 autonomic changes also observed include:  increased BP, HR, and bladder pressure, pupillary mydriasis, hypersecretion of skin and salivary glands, cyanosis of skin
 
 duration: 2-5 minutes
 
 postictally, patient is lethargic/sleepy lasting several minutes to hours
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of absence seizures (petit mal) |  | Definition 
 
        | onset between 5-12 years 
 brief episodes of transient loss of awareness without gross convulsive movements
 
 in addition, most patients will have simple automatisms:  blinking of eyes, drooping of head, chewing
 
 less frequently seen are mild clonic, tonic, and/or atonic components to seizure
 
 duration:  short (10-45 seconds), patient usually unaware of occurrence
 
 abrupt recovery without after effects
 
 important in children to differentiate from complex partial seizures since treatment and prognosis vary
 incontrast to absence, complex partial seizures usually have a longer duration, are often preceded by aura, and typically have a brief period of postictal confusion
 the EEG pattern is markedly different
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of atypical absence seizure |  | Definition 
 
        | onset between 1-7 years 
 similar to typical absence except for loss of responsiveness during seizure is often less complete and more gradual in onset and cessation
 
 also, clonic, tonic, and atonic components (increase or decrease in muscle tone) are more pronounced that in typical absence
 
 commonly seen in patients with Lennox-Gastaut syndrome
 
 this syndrome is also characterized by an encephalopathy with mental retardation or structural CNS damage
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of atonic seizures |  | Definition 
 
        | onset usually between age of 2-5 years 
 sudden and total loss of muscle tone and posture control; patient drops to the ground; not necessarily associated with loss of consciousness
 
 must wear helmet to protect from head injury
 
 may or may not have postictal symptoms
 
 druation:  10-60 seconds
 
 brief, if any, postictal symptoms
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of myoclonic seizures |  | Definition 
 
        | sudden, brief shock-like contractions which may involve the entire body or be confined to face, trunk, or extremities 
 may be symptom of an organic CNS disorder (ischemia, trauma, progressive neurologic disorders)
 
 duration 10-60 seconds
 
 brief, if any, postictal symptoms
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of tonic seizures |  | Definition 
 
        | sudden increase in muscle tone WITH LOSS OF CONSCIOUSNESS and autonomic signs (pupil dilation) 
 primarily seen in younger children; commonly associated with metabolic disorder or underlying neurological deficit
 
 duration:  10-60 seconds
 
 brief, if any, postictal symptoms
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of infantile spasms |  | Definition 
 
        | consist of sudden flexion of the head with abduction and extension of arms, accompanied by flexion of knees and often a little grunt or cry; spasms may also be extension rather than flexion 
 spasms commonly occur in series of 2 or more
 
 onset commonly between 4-7 months
 
 mortaility rate 11-23%; developmental retardation 80-90%
 
 characterized by spasms, developmental retardation
 
 unique among seizure types in responsiveness to ACTH/corticosteroids
 |  | 
        |  | 
        
        | Term 
 
        | characteristics of febrile seizures |  | Definition 
 
        | convulsions that occur with fever (>38C) in children between 6 months and 6 years, not secondary to an infection of brain or meninges 
 strong genetic predisposition
 
 primarily occur as generalized tonic-clonic seizures, but partial seizures can occur
 
 increased risk:  preexisting neurologic abnormaility, family history of afebrile seizures
 |  | 
        |  | 
        
        | Term 
 
        | drug entities and conditions associated with drug-induced seizures |  | Definition 
 
        | BUPROPION (>450 MG/DAY) CIPROFLOXACIN (QUINOLONES) - have to be adjusted for renal insufficiency!
 IMIPENEM (BETA-LACTAMS)
 MEPERIDINE (RENAL INSUFFICIENCY)
 THEOPHYLLINE
 AED WITHDRAWAL - even if the patient isn't using it for seizures
 
 clomipramine
 clozapine
 cyclosporine
 lithium
 loxapine
 phenothiazines
 TCAs
 tramadol
 alcohol (withdrawal)
 amphetamines
 cocaine
 flumazenil - BZD antagonist
 
 excitatory/inhibitory neurotransmitters
 excitatory:  glutamate, ACh, NE, histamine, corticotropin releasing factor
 inhibitory:  GABA, DA
 
 OFTEN DOSE RELATED, MAY BE ADDITIVE
 |  | 
        |  | 
        
        | Term 
 
        | AEDs that are drugs of choice for absence seizures |  | Definition 
 
        | ETHOSUXIMIDE is 1st line for absence seizures 
 valproate is indicated for absence seizures
 rufinamide (efficacy shown)
 |  | 
        |  | 
        
        | Term 
 
        | AEDs to avoid in absence seizures |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | non-pharm and lifestyle modifications for a patient with epilepsy |  | Definition 
 
        | importance of adherence: did medication fail or did adherence fail?
 good habits
 patient education
 support system engagement
 self-assessment methods:  pill box, electronic bottle caps, mark date next refill due, journals
 
 adjunctive non-pharm therapy:
 
 sleep deprivation, stress, and a poor diet can increase incidence of seizures
 
 counsel all patients to incorporate:
 consistent sleep habits, adequate sleep
 sound nutrition, regular meals
 routine exercise
 stress reduction
 
 avoid recreational drugs
 
 avoid excessive amounts of alcohol
 |  | 
        |  | 
        
        | Term 
 
        | how/when phenytoin serum concentrations can increase significantly with a small increase in dose |  | Definition 
 
        | phenytoin has saturable hepatic metabolism (low dose = 1st order; high dose = 0 order) 
 at high plasma concentrations small increases in dose can result in very large increases in plasma concentrations (therapeutic plasma levels can quickly turn toxic)
 |  | 
        |  | 
        
        | Term 
 
        | the importance of albumin monitoring with respect to total phenytoin serum concentration |  | Definition 
 
        | REFERENCE RANGE: 5-20 mcg/mL TOTAL PHENYTOIN
 0.5-2 mcg/mL FREE PHENYTOIN
 
 free vs. total phenytoin levels:
 total requires albumin monitoring
 |  | 
        |  | 
        
        | Term 
 
        | contrast phenytoin and fosphenytoin |  | Definition 
 
        | PHENYTOIN: 
 DOSE:  18-20 mg/kg IV
 
 rate: (no IV push)
 max 50 mg/min
 decrease rate in those with underlying CV disease or hypotension; in elderly
 
 poor water solubility and stability
 
 FOSPHENYTOIN:
 
 no anticonvulsant properties; desired activity due to phenytoin
 
 DOSE: 18-20 mg PE/kg (same as phenytoin)
 
 rate:
 max 150 mg PE/min
 decrease rate in those with underlying CV disease or hypotension; in elderly
 
 ADRs:
 most common - CNS (same as phenytoin)
 decreased infusion related events (pain, burning, cording)
 decreased hypotension during infusion; decreased HR and BP may be seen after infusion completed or stopped
 transient pruritis or paresthesias; dose and rate related
 |  | 
        |  | 
        
        | Term 
 
        | describe idiosyncratic and dose related ADRs of phenytoin |  | Definition 
 
        | bioavailability differs with different formulations of phenytoin (all not directly interchangeable) 
 NON-DOSE DEPENDENT:
 gingival hyperplasia
 hirsuitism (hair growth)
 osteoporosis
 thickening of facial features
 acne
 cardiac arrhythmias
 hypothyroidism
 peripheral neuropathy
 SJS
 
 DOSE RELATED:
 nystagmus
 diplopia
 ataxia
 confusion/delirium
 coma
 
 IDIOSYNCRATIC:
 blood dyscrasias
 rash
 immunologic reaction
 
 MONITORING:
 
 CBC with diff
 baseline and annual LFT
 phenytoin level every 2 weeks and with interacting drug addition
 albumin prn
 serum Ca
 |  | 
        |  | 
        
        | Term 
 
        | AEDs associated with significant hyponatremia |  | Definition 
 
        | carbamazepine oxcarbazepine
 |  | 
        |  | 
        
        | Term 
 
        | AEDs that are strong inducers of CYP450 isoenyzmes |  | Definition 
 
        | phenobarbital phenytoin
 primidone
 carbamazepine:  auto-induction (steady state at 28 days, need to titrate dose q 4-6 weeks)
 oxcarbazepine:  no auto-induction observed
 topiramate:  at doses above 200 mg/day; counsel patients about alternative birth control or raise estradiol dose
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | somnolence confusion
 cognitive impairment
 respiratory depression
 hypotention
 osteoporosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NAUSEA vomiting (although long half-life, split dose to BID to improve tolerability)
 drowsiness
 anorexia
 GI upset
 sleep disturbances
 aggression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | aplastic anemia LEUKOPENIA
 HYPONATREMIA
 OSTEOPOROSIS
 SJS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HYPONATREMIA blood dyscrasias rare
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | WEIGHT GAIN TREMOR
 SOMNOLENCE
 GI DISTRESS
 thrombocytopenia (dose related)
 pancreatitis
 PCOS
 hepatic failure (mostly youths < 10 years)
 hyperammonemia
 alopecia (temporary)
 
 BBW for hepatic failures, especially in patients < 2 years
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SOMNOLENCE BEHAVIORAL ABNORMALITIES (MOOD CHANGES/IRRITABILITY)
 WELL TOLERATED GENERALLY
 
 MONITOR: RENAL FUNCTION
 
 NO SIGNIFICANT DRUG INTERACTIONS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | contraindicated in those with SULFONAMIDE ALLERGY 
 associated with significant baseline weight loss
 
 PARAESTHESIAS
 OLIGOHYDROSIS
 HYPERTHERMIA
 NEPHROLITHIASIS
 ANGLE-CLOSURE GLAUCOMA
 METABOLIC ACIDOSIS
 PSYCHOMOTOR SLOWING
 
 monitor:  renal function, baseline and periodic Na bicarb
 
 patients should drink copious amounts of water as it is a carbonic anhydrase inhibitor, it may predispose patients to renal stones
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | similar to zonisamide 
 weight loss
 paresthesias
 oligohydrosis
 hyperthermia
 nephroliathiasis
 angle-closure glaucoma
 metabolic acidosis
 psychomotor slowing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | benign rash (associated with dose and titration internal; more common in children) SJS
 hepatotixicity
 
 MONITORING:  DERMATOLOGIC ADRS
 
 DRUG INTERACTIONS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | saturable absorption in GI and BBB 
 FATIGUE
 WEIGHT GAIN
 ATAXIA
 PERIPHERAL EDEMA
 
 MONITORING:  RENAL FUNCTION
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CV controlled substance 
 renally eliminated, dosage adjustments
 
 SIMILAR ADRS TO GABAPENTIN:
 PERIPHERAL EDEMA (CAUTION WITH TZDS)
 DIZZINESS AND SOMNOLENCE (may impair patient's ability to drive)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diziness tremor
 somnolence
 euphoria
 
 monitoring:  ECG, renal function
 
 hypersensitivity reactions (rash, multi-organ), cardiac conduction disturbances
 
 CV:  "BZD-like" effects
 
 primarily renally excreted
 
 limited drug interactions (not affected by other AEDs or OCs)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | somnolence fever
 rash
 N/V
 SJS
 shortened QT interval
 increased incidence of seizures?
 
 monitoring:  ECG, hypersensitivity reactions (rash, multi-organ)
 
 cardiac conduction disturbances:  DOSE RELATED QT SHORTENING
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | OPHTHALMOLOGIC TOXICITIES visual field defects
 progressive and permanent peripheral vision loss
 not regained after discontinuation of medication
 
 somnolence
 HA
 irritability
 dizziness
 peripheral neuropathy
 
 monitoring:  renal function, ophthalmologic exam
 
 RESTRICTED ASSESS PROGRAM
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | weight loss nausea
 HE
 APLASTIC ANEMIA
 ACUTE HEPATIC FAILURE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | somnolence tremor
 cognitive impairment
 MAY INDUCE SEIZURES IN NON-EPILEPTICS:  CONCERN ABOUT USING THIS DRUGS AS MONOTHERAPY
 
 monitoring:  renal function
 
 potential long-term ophthalmologic effects
 |  | 
        |  | 
        
        | Term 
 
        | 3 pairs of AEDs that are most similar to each other |  | Definition 
 
        | zonisamide and topiramate 
 carbamazepine and oxcarbazepine
 
 gabapentin and pregabalin
 |  | 
        |  | 
        
        | Term 
 
        | AEDs that are renally excreted |  | Definition 
 
        | levetiracetam zonisamide
 topiramate
 gabapentin
 pregabalin
 lacosamide
 viagabatrin
 tiagabine
 |  | 
        |  | 
        
        | Term 
 
        | rationale behind lamotrigine's titration schedule |  | Definition 
 
        | DOSE TITRATION OVER 5 WEEKS OR MORE 
 a rash can develop with lamotrigine, especially if it is titrated too rapidly
 |  | 
        |  | 
        
        | Term 
 
        | rationale behind medication order of administration for status epilepticus |  | Definition 
 
        | status epilepticus defined as: > 30 minutes of continuous seizure activity
 2 or more sequential seizures without full recovery of consciousness between seizures
 
 goals in management of SE:
 terminate electrical and clinical seizure activity within 30 minutes
 prevent recurrence of seizures
 insure adequate cardiorespiratory function and brain oxygenation
 correct any precipitating factors such as hypoglycemia, electrolyte imbalance, fever
 stabilize metabolic balance by prevention and correction of lactic acidosis, dehyration
 PRIMARY GOAL = STOP SEIZURE ACTIIVTY
 
 INITIATE THERAPY WITH IV BENZODIAZEPINE:
 diazepam or lorazepam
 help cease the seizure
 
 INITIATE AED THERAPY WITH HYDANTOIN:
 phenytoin sodium or fosphenytoin sodium
 prevents recurrence of sizures
 SLOWER ONSET OF ACTION THAN BZDS (10-30 MINUTES)
 |  | 
        |  | 
        
        | Term 
 
        | how long should phenytoin be continued after a single seizure episode secondary to metabolic disturbance? |  | Definition 
 
        | once seizure is controlled, patient should be tapered off phenytoin |  | 
        |  | 
        
        | Term 
 
        | rationale for continuing AED therapy during pregnancy |  | Definition 
 
        | RISK VS. BENEFIT (SEIZURES CAN BE FATAL) 
 ~90% OR MORE HAVE SATISFACTORY OUTCOMES
 
 teratogenicity increased with polypharmacy, high doses
 
 highest risk within first weeks of pregnancy
 
 adverse pregnancy outcomes associated with maternal seizures (growth, psychomotor, and mental retardation)
 |  | 
        |  | 
        
        | Term 
 
        | AEDs associated with major congenital malformations |  | Definition 
 
        | most AEDs are considered teratogenic 
 PREGNANCY CATEGORY D:
 PHENYTOIN
 VALPROATE
 PHENOBARBITAL
 CARBAMAZEPINE
 TOPIRAMATE
 
 rest Category C
 |  | 
        |  | 
        
        | Term 
 
        | which has a much better prognosis for seizure freedom following treatment:  generalized tonic clonic seizures, or complex partial seizures? |  | Definition 
 
        | generalized tonic clonic seizures |  | 
        |  | 
        
        | Term 
 
        | which has a much better prognosis for seizure freedom following treatment:  generalized tonic clonic seizures, or complex partial seizures? |  | Definition 
 
        | generalized tonic clonic seizures |  | 
        |  | 
        
        | Term 
 
        | what is the treatment of choice for complex partial seizures? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the treatment of choice for generalized tonic clonic seizures? |  | Definition 
 | 
        |  |